Abdominal pain
Drug research and approvals for abdominal pain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 105 studies of abdominal pain are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.
- Recruiting worldwide: 105
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- A Clinical Trial to Evaluate the Effects of a Supplement on Gut HealthNCT07927907 · Not applicable · Peach Perfect · starts Feb 1, 2026
- Effects of a Prebiotic-Probiotic Combination on Constipation Symptoms and Quality of LifeNCT07923279 · Not applicable · Seoul National University Hospital · starts Jul 10, 2026
- Comparing Two Laparoscopic Techniques for Hernia Repair in ChildrenNCT07915830 · Not applicable · Quaid-e-Azam Medical College · starts May 12, 2026
- Tramadol Versus Morphine for Postoperative Pain Relief Following Laparoscopic Abdominal SurgeryNCT07914335 · Not applicable · Centre Hospitalier Universitaire, Amiens · starts Dec 22, 2025
- Implementation of a Pain Management Plan in Major Open Abdominal Surgeries.NCT07901582 · Not applicable · National and Kapodistrian University of Athens · starts Nov 22, 2025
- Ultrasound Guided- Chemical Rectus Sheath Block for Chronic Pain After Abdominal Midline Incision in Cancer SurgeriesNCT07855380 · Not applicable · National Cancer Institute, Egypt · starts May 1, 2026
- Dexmedetomidine Versus Ketamine in TAP Block for Postoperative Analgesia After Total Abdominal HysterectomyNCT07845643 · Phase 4 · Bangladesh Medical University · starts Oct 1, 2026
- Epidural Analgesia Versus Opioid-sparing Analgesia for Open Ventral Hernia Repair With Transversus Abdominis ReleaseNCT07840183 · Phase 4 · Northwestern University · starts Sep 25, 2026
- Nerve Block for Severe Abdominal Pain in the Emergency DepartmentNCT07826936 · Early Phase 1 · University of California, Irvine · starts Oct 11, 2024
Approved 3
- GemfibrozilPeroxisome proliferator-activated receptor alpha agonist
- Cromolyn
- Niacin
Phase 3 9
- ScopolamineMuscarinic acetylcholine receptor M1 antagonist
- RopivacaineSodium channel alpha subunit blocker
- AcetaminophenCyclooxygenase inhibitor
- AlbuterolBeta-2 adrenergic receptor agonist
- KetorolacCyclooxygenase inhibitor
- TramadolMu opioid receptor agonist
- Ibandronic acidFarnesyl diphosphate synthase inhibitor
- AzithromycinBacterial 70S ribosome inhibitor
- Butylscopolamine
Phase 2 9
- NepadutantNeurokinin 2 receptor antagonist
- SimethiconeAntifoaming agent
- BupivacaineSodium channel protein type IV alpha subunit blocker
- CyproheptadineHistamine H1 receptor antagonist
- TriamcinoloneGlucocorticoid receptor agonist
- LevobupivacaineSodium channel protein type IV alpha subunit blocker
- OlorinabCannabinoid CB2 receptor agonist
- FasinumabBeta-nerve growth factor inhibitor
- Cannabinol
Phase 1 or earlier 2
How its trials ended
310 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 76 whose ending is known, 37% met their primary endpoint, 14% missed it and 49% stopped early.
- Completed, result not reported14848%
- Ongoing4515%
- Status unknown4113%
- Met its primary endpoint289%
- Stopped: other or unclear206%
- Stopped: enrollment or feasibility134%
- Missed its primary endpoint114%
- Stopped: sponsor or business decision31%
- Stopped: lack of efficacy1<1%
| Date | Drug | Sponsor | Status |
|---|---|---|---|
| Sep 16, 2002 | Human gammaglobulinTreatment of gastrointestinal disturbances (to include constipation, diarrhea, and abdominal pain) associated with regression-onset autism… | Latona Life Sciences, Inc. | Designated |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA